Quality assessment of Diflucan® tablets distributed online: Diflucan® distributed online [0.03%]
网络销售的氟康唑片质量评估
Tomoko Sanada,Myu Ohnishi,Naoko Yoshida et al.
Tomoko Sanada et al.
Background: Falsified medical products have been reported worldwide. Falsified medicines with poor quality are a potential health hazard. Some Internet sites advertise fluconazole (Diflucan®), an antifungal medicine used...
Evaluation of pharmacists' awareness of illegal online pharmacies and perceived impact on safe access to medicines [0.03%]
药师对非法在线药店的认识及其对安全获得药物的影响评估
John B Hertig,Shannon M James,Connor J Hummel et al.
John B Hertig et al.
Background: An estimated 95% of all online pharmacies operate unlawfully. Illegal online pharmacies distribute substandard and falsified medical products that may result in patient harm and suboptimal treatment, leading t...
"It's a walk of shame": Experiences of unintended pregnancy and abortion among sexual- and gender-minoritized females in urban India [0.03%]
印度城市性少数女性意外怀孕及堕胎经历探讨
Jessamyn Bowling,Megan Simmons,Donna Blekfeld-Sztraky et al.
Jessamyn Bowling et al.
Background: Unintended pregnancy and safe abortion access in India remain critical public health concerns. The health of sexual- and gender-minoritized females (SGMF; those assigned female at birth and identify as other t...
Legal and non-legal barriers to abortion in Ireland and the United Kingdom [0.03%]
爱尔兰和英国妨碍堕胎的法律与非法律屏障
Sydney Calkin,Ella Berny
Sydney Calkin
This article compares abortion laws, regulations and access patterns in the United Kingdom and the Republic of Ireland. We focus in most detail on the Republic of Ireland, Northern Ireland and England with a shorter discussion of Scotland a...
Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications [0.03%]
波黑单克隆抗体的可及性和可获得性：研究发现和影响
Biljana Tubic,Vanda Marković-Peković,Saša Jungić et al.
Biljana Tubic et al.
Background: Monoclonal antibodies (mAbs) represent the most numerous and significant group of biotherapeutics. While mAbs have undoubtedly improved treatment for many chronic diseases, including inflammatory diseases, the...
Medicine quality in high-income countries: The obstacles to comparative prevalence studies [0.03%]
高收入国家的药品质量：比较流行病学研究障碍
Bernard David Naughton,Ebru Akgul
Bernard David Naughton
The entry of falsified and substandard medicines into the legitimate pharmaceutical supply chain has negative impacts on healthcare systems, patient safety, and patient access to medicine. The COVID-19 pandemic has highlighted the importanc...
A survey of pediatric hematologists/oncologists' perspectives on single patient Expanded Access and Right to Try [0.03%]
儿科血液病/肿瘤专家们对单个患者扩大使用计划和尝试权利的态度调查报告摘要
Carolyn Riley Chapman,Hayley M Belli,Danielle Leach et al.
Carolyn Riley Chapman et al.
Introduction: Physicians in the United States play an essential role guiding patients through single patient pre-approval access (PAA) to investigational medical products via either the Food and Drug Administration (FDA)'...
Integrating physical and mental healthcare: Facilitators and barriers to success [0.03%]
身心健康的整合：成功实施的促进因素和障碍
Karen Monaghan,Travis Cos
Karen Monaghan
Introduction: Effective and appropriate provision of mental healthcare has long been a struggle globally, resulting in significant disparity between prevalence of mental illness and access to care. One attempt to address ...
Point-of-care high-sensitivity assay on PATHFAST as the backup in the emergency room [0.03%]
基于PATHFAST的急诊科POCT高敏检测系统应用分析
Joško Osredkar,Katja Krivic,Teja Fabjan et al.
Joško Osredkar et al.
Aim: Although the levels of cardiac troponin I (cTnI) have proved to be a useful diagnostic biomarker of acute myocardial infarction, there are a wide variety of point-of-care (POC) analysers, which provide measurements o...
Access to unlicensed medicines, who should pay when they are not provided for free? [0.03%]
未上市药物的获取：当其无法免费获得时，谁应该买单？
Kieron David Lewis
Kieron David Lewis
The rising cost of clinical development, license submissions, commercial product launches, and affiliate management in all countries around the world, coupled with the ethical obligation to ensure that eligible patients have access to new t...